Live in harmony with ENTEROLACTIS®: online the new website
Visit the new website dedicated to the complete range of ENTEROLACTIS® products
The SOFAR line of food supplements is now being expanded with PROTEGGI C!
PROTEGGI C, a new Vitamin C based food supplement conveniently packaged with 120 tablets of 1000 mg of Vitamin C
Big things sometimes have a microscopic beginning…
We are proud to announce that our new and futuristic Laboratory, which is also a Center for Research and Development in the field of Microbiota and Probiotics, is now operational!
SOFAR Americas Introduces Innovia Probiotic Micro-Shots for Kids
Innovia KIDS Delivers Safe and Effective Probiotics plus Vitamins Specifically Formulated for Children.
SOFAR’s success continues in Romania
The Romanian market continues to embrace SOFAR’s “Made in Italy” healthcare products; for example, Enterolactis, available in various forms; and Cistiflux, the dietary supplement that promotes urinary tract health.
Nutraceutical market: SOFAR is in the top 10 companies and number 1 in the gastrointestinal sector
In the nutraceutical market, SOFAR has once again won top positions in the ranking of healthcare companies.
SOFAR social media presence now online in Russia
To introduce Russian consumers to SOFAR’s product and health missions, and engage them in learning more about how our products can benefit them, we have launched social media channels dedicated to the products.
SOFAR opened its new branch in Moscow
The “Representative office of SOFAR” Moscow has been established with the objective to help improve the quality of life of the millions of Russian patients and consumers.
SOFAR remains a leader in the extra-pharmaceutical market
In October, newly released data from New Line Market Research ranked SOFAR second in the “Best Performer in Pharmacies” in Italy.
Our Probiotic Lands in Australia
We are proud to introduce our LP-DG™ probiotic strain (Lactobacillus paracasei DG) into the Australian market where consumers can enjoy its benefit as Biotik™.
SOFAR acknowledged as “Best Performer in Pharmacy” Company
In October, newly released data from New Line Market Research ranked SOFAR second in the “Best Performer in Pharmacies” in Italy.
The enduring rewards of Research and Innovation. Our CEO, Andrea Biffi, talks to Fortune
Andrea Biffi, SOFAR’s CEO, summarizes our company’s recent growth in an extensive interview with Fortune Italia.
Innovia™ Nectar Digestion Enters the Italian Market
Following its outstanding success in the US market, our Innovia™ Nectar Digestion has launched throughout Italy.
CistiFlux is Confirmed as a Brand Best Performer
Dietary supplements as the best performers in August 2018 with a significant increase in turnover (+4.3%)
SOFAR Has Leading Presence in Non-Pharmaceuticals
SOFAR has placed number 3 in the top 10 companies in the dietary supplements category of the non-pharmaceuticals sector in Italy, with a market share of 2.7%, according to New Line Market Research.
SOFAR Announces its Collaboration with Plasma Surgical at the XIII National SEGi Congress
SOFAR Announces its Collaboration with Plasma Surgical at the XIII National SEGi Congress
Happy 50th Birthday to SOFAR!
In 1968 SOFAR was founded as an Italian distributor of drugs for third parties. Our company has come a long way since then!
Enterolactis remains dietary supplement leader in Italy
SOFAR’s Enterolactis® holds first place of the top 15 brands in the dietary supplements sector in Italy.
Innovia Nectar: our successful probiotic product arrives in the USA
Innovation, research and “Made in Italy” quality have landed in the USA with SOFAR’s distinctive probiotic Innovia Nectar, launched exclusively through our American subsidiary, SOFAR Americas.
